文献速递腹部US

CEUS LI-RADS诊断肝细胞癌价值的Meta分析

The Value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
PubMed 文献 · J Ultrasound Med · 2021-10-07

该Meta分析纳入13项研究共6491例患者,系统评价超声造影肝脏影像报告和数据系统(CEUS LI-RADS)对肝细胞癌的诊断效能。合并敏感度0.72(95%CI 0.70-0.73),特异度0.92(95%CI 0.91-0.93),AUC 0.8406,准确率0.77。结论认为CEUS LI-RADS是诊断HCC有效且有前景的方法。

要点

  • CEUS LI-RADS对HCC诊断特异度高(0.92),敏感度中等(0.72)。
  • 合并阳性似然比8.02,阴性似然比0.31,诊断比值比27.91。
  • 总体AUC 0.8406,准确率0.77,支持其作为HCC诊断工具。

核心结论

  • CEUS LI-RADS是诊断HCC有效且有前景的方法。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Medline和Embase数据库。
  • 最终纳入13项研究,共6491例患者。
  • 计算合并敏感度、特异度、诊断比值比、阳性及阴性似然比、AUC、准确率和F1评分以评估诊断价值。

诊断标准与关键数值

  • 合并敏感度为0.72(95%CI 0.70-0.73),合并特异度为0.92(95%CI 0.91-0.93)。
  • 阳性似然比为8.02(95%CI 4.93-13.06),阴性似然比为0.31(95%CI 0.27-0.37)。
  • 合并诊断比值比为27.91(95%CI 15.39-50.63),总体AUC为0.8406,准确率为0.77。

临床应用与阅片要点

  • CEUS LI-RADS高特异度有助于确认HCC,中等敏感度提示阴性结果不能完全排除HCC。
  • 阳性似然比8.02提示阳性结果时HCC概率显著增加,阴性似然比0.31提示阴性结果时概率中度降低。

局限性

  • 原文未明确报告纳入研究的异质性、发表偏倚及方法学质量评价结果。
  • Meta分析基于已发表研究,可能存在选择偏倚和发表偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study is to systematically evaluate the diagnostic ability of the contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) in hepatocellular carcinoma (HCC).

METHODS: We searched relevant studies from PubMed, Medline, and Embase database. After literature search, duplicate removal, and data extraction, we calculated and analyzed the pooled sensitivity, pooled specificity, pooled odds ratios of diagnostic, pooled likelihood ratio (LR) of positive and negative, and area under the curve (AUC), accuracy, and F1 score to evaluate the diagnostic value of CEUS LI-RADS for HCC.

RESULTS: Thirteen studies and 6491 patients were included in this analysis. The pooled sensitivity and pooled specificity were 0.72 (95% confidence interval [CI], 0.70-0.73) and 0.92 (95% CI, 0.91-0.93), respectively. The positive LR was 8.02 (95% CI, 4.93-13.06) and the negative LR was 0.31 (95% CI, 0.27-0.37). The pooled diagnostic odds ratio was 27.91 (95% CI, 15.39-50.63). The overall AUC was 0.8406 and the accuracy was 0.77.

CONCLUSIONS: CEUS LI-RADS is an effective and promising method to diagnose HCC.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Peng J, Zhang T, Wang H, et al. The Value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. J Ultrasound Med. 2021. PMID: 34617296. doi:10.1002/jum.15837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。